Mesa Laboratories, Inc. (MLAB)
MLAB Stock Price Chart
Key Info
| Market Cap | 1.39B |
| Revenue (ttm) | 127.66M |
| Net Income (ttm) | -2.61M |
| Shares Out | 5.11M |
| EPS (ttm) | -0.56 |
| PE Ratio | n/a |
| Forward PE | 35.21 |
| Dividend | $0.64 |
| Dividend Yield | 0.24% |
Stock Quote
| Trading Day | December 4 |
| Last Price | $271.85 |
| Previous Close | $266.89 |
| Change ($) | 4.96 |
| Change (%) | 1.86% |
| Day's Open | 267.49 |
| Day's Range | 265.18 - 273.05 |
| Day's Volume | 26,298 |
| 52-Week Range | 190.33 - 289.82 |
MLAB Stock News
Mesa Labs (MLAB) delivered earnings and revenue surprises of 78.50% and 5.25%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
LAKEWOOD, Colo., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the second quarter (“2Q21”) and six months ended September 30, 2020.
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LAKEWOOD, Colo., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a ...
The S&P 500 index saw its trailing 12-month revenue per share increase by approximately 4% every year over the past five years.
Mesa Labs (MLAB) delivered earnings and revenue surprises of -6.18% and -5.55%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
LAKEWOOD, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (“1Q21”).
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Source: Mesa Laboratories, Inc. – June 16, 2020 11:30 AM ET
Source: Mesa Laboratories, Inc. - June 9, 2020 8:15 PM ET
Source: Mesa Laboratories, Inc. – June 8, 2020 4:01 PM ET
Mesa Labs (MLAB) delivered earnings and revenue surprises of -36.45% and -0.85%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results.
LAKEWOOD, Colo., June 01, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q20”) and full year ended March 31, 2020 (“FY20”).
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LAKEWOOD, Colo., May 15, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced the election of Shannon Hall to its Board of Directors. Shannon previously led the Li...
LAKEWOOD, Colo., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a re...
Mesa Labs (MLAB) delivered earnings and revenue surprises of 0.58% and -1.79%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
LAKEWOOD, Colo., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and co...
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mesa Labs (MLAB) delivered earnings and revenue surprises of 7.18% and 2.29%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Mesa Laboratories Inc. is up almost 300 percent over the last 6 years.
About MLAB
Mesa Laboratories designs, manufactures, and markets quality control instruments and disposable products in the United States, Canada, Europe, and Japan. The company's Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and offers testing services. This segment also provides chemical and cleaning indicators that are used to assess the effectiveness of sterilization and cleaning processes. Its Instr... [Read more...]
| Industry Scientific & Technical Instruments | Founded 1982 |
| CEO Gary Owens | Employees 460 |
| Stock Exchange NASDAQ | Ticker Symbol MLAB |
Financial Performance
In 2019, MLAB's revenue was $117.69 million, an increase of 14.11% compared to the previous year's $103.14 million. Earnings were $1.35 million, a decrease of -81.97%.
Analyst Forecasts
The average 12-month stock price forecast for MLAB is 281.50, which is an increase of 3.55% from the latest price.